Polpharma is constantly striving to develop innovation and efficient functioning in a changing and unpredictable reality. For this reason, the organisation has decided to focus on developing leaders so that they are able to face the challenges of a rapidly changing world.
Polpharma invited Impact and another partner to support the process of cultural change.
The overriding goal of the Impact programme was to strengthen leadership and cultural change towards a more modern one, adapted to the changing world and environment of VUCA (volatile, uncertain, complex, ambiguous).
The accompanying objectives were:
- To build a coherent approach to leadership throughout the organisation
- To enhance leadership effectiveness
- To broaden the scope of leadership styles used in the company (with an emphasis on coaching and visionary styles)
- To build cooperation between different parts of the organisation
Impact proposed a 3-module programme of strengthening and developing leadership skills for 120 N-1 and N-2 managers and directors in Poland, Kazakhstan, Russia and Spain. This international programme was delivered in all four countries in three different languages.
Participants took part in a series of interactive workshops, and had the opportunity to discuss and exchange opinions with the management team, which influenced the sense of involvement in the change process.
The workshops were based on Impact's own Experiential Learning methodology. Participants had the opportunity to experiment, test new skills and behaviours in a difficult, often outside their comfort zone, but safe environment.
There were many concrete examples of changes in attitudes among directors in the course of the programme.
“The results of the review confirmed that the number of managers who present strategic and developing styles increased. Moreover, the programme had a very positive impact on the inter-departmental / cross-functional cooperation, which is very important in such a large and diverse company as Polpharma."
Justyna Jedlińska, Employee Development Director at the Polpharma Group